cupure logo

Revolution Medicines News

FDA Approves Daraxonrasib, a New Drug for Pancreatic Cancer, Doubling Survival

FDA Approves Pancreatic Cancer Drug Daraxonrasib

Revolution Medicines is a biotechnology company that develops targeted therapies for cancer, including the FDA-approved drug daraxonrasib.